+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Women's Health Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Women's Health Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Menopause Market - Global Forecast 2026-2032 - Product Thumbnail Image

Menopause Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Injectable Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Injectable Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
From
Recombinant Proteins Market 2025-2029 - Product Thumbnail Image

Recombinant Proteins Market 2025-2029

  • Report
  • April 2025
  • 203 Pages
  • Global
From
From
End-Stage Renal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator